Latest GLP-1 Therapies Research Papers

yesterday • Cardiology in the young

Patient outcomes with incretin-based drugs and SGLT2 inhibitors in obesity-related heart failure with preserved heart pumpingPatient-centred outcomes with incretin-based therapies and sodium-glucose cotransporter 2 inhibitors in obesity-related heart failure with preserved ejection fraction: a programme-level systematic review and meta-analysis.

📖 Top 50% JournalArticle

yesterday • Journal of health care for the poor and underserved

Medicaid Coverage Rules and Real-World Challenges in Getting TirzepatideCoverage Criteria vs. Clinical Reality: Navigating Medicaid Barriers to Tirzepatide Access.

📖 Top 30% JournalCase Reports

yesterday • The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry

How Drugs Acting on GLP-1 Receptors May Affect Thinking About FoodGLP-1 Receptor Agonist Effects on Food-Related Cognition: A Cognitive Neuroscience Framework.

🎖️ Top 10% JournalArticle

yesterday • Annals of human biology

How GLP-1 receptor drugs relate to the rise of obesity, inactivity, and loneliness from an evolutionary viewEvolutionary perspectives on GLP-1 receptor agonists and the modern obesity, sedentary behaviour, and loneliness epidemics.

📖 Top 50% JournalArticle

yesterday • Diabetology international

Monocyte GIP receptor levels linked to weight loss and liver health improvements after switching to tirzepatide in type 2 diabetes patientsBaseline monocyte GIP receptor mRNA expression is associated with reductions in body weight and FIB-4 index after switching to tirzepatide in patients with type 2 diabetes.

📖 Top 50% JournalArticle

yesterday • Balkan medical journal

Comparing GLP-1 Receptor Agonists with Empagliflozin or Dapagliflozin in People with Fatty Liver Disease and Heart FailureGLP-1 Receptor Agonists Versus Empagliflozin or Dapagliflozin in the MASLD-Heart Failure Phenotype: An Exploratory Propensity-Matched Cohort Study.

📖 Top 30% JournalArticle

yesterday • Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research

GLP-1 increases IL-27 production in immune cells by activating the PI3K/AKT signaling pathwayGLP-1 Enhances IL-27 Production in RAW264.7 Macrophages Via Activation of the PI3K/AKT Pathway.

📖 Top 30% JournalArticle

yesterday • Diabetology international

How Depression Levels Relate to Different Mental Health Paths During GIP and GLP-1 Receptor Agonist TreatmentsBaseline depressive-symptom severity and divergent psychological trajectories during GIP and/or GLP-1 receptor agonist therapy: a prospective ecological momentary assessment study.

📖 Top 50% JournalArticle

yesterday • Bone

Glucagon-like peptide-1 receptor agonists and their impact on bone metabolism: A review and analysis of controlled trials with mainly first-generation drugsThe effect of glucagon-like peptide-1 receptor agonists on bone metabolism: A systematic review and meta-analysis of randomized placebo-controlled trials of predominantly first-generation agents.

Article

yesterday • Annals of internal medicine

In Type 2 Diabetes, Using Both SGLT2 Inhibitors and GLP-1 Receptor Agonists Together Does Not Lower Major Heart or Kidney Problems Compared to Using Either One AloneIn T2D, combined SGLT2i + GLP-1 RA vs. either alone does not reduce MACE or renal outcomes.

🥈 Top 2% JournalArticle

yesterday • Molecular pharmaceutics

Imaging of a drug targeting both GLP-1 and GIP receptors using a radioactive tracerPET Imaging of Dual GLP-1R and GIPR Targeting with [18F]AlF-NOTA-Asp2-Tirzepatide.

📖 Top 20% JournalArticle

yesterday • Indian journal of pharmacology

Severe low blood sodium linked to tirzepatide with signs of inappropriate antidiuretic hormone releaseTirzepatide-associated severe euvolemic hyponatremia with syndrome of inappropriate antidiuretic hormone secretion-compatible biochemical features.

📖 Top 50% JournalCase Reports

yesterday • Critical pathways in cardiology

Semaglutide’s effects on heart-related deaths: a systematic review and analysis of heart protectionSemaglutide and Cardiovascular Death: a Systematic Review and Meta-Analysis Cardioprotective Efficacy of Semaglutide.

Article

yesterday • Journal of diabetes and metabolic disorders

Effectiveness and safety of semaglutide compared to placebo in adults with overweight or obesity without diabetesEfficacy and safety of semaglutide versus placebo in adults with overweight or obesity without diabetes: updated meta-analysis of randomized trials.

📖 Top 50% JournalArticle

2 days ago • Kidney research and clinical practice

Effects of combining two diabetes medications on people with chronic kidney disease in real-world settingsEffect of combined sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonist therapy in patients with chronic kidney disease: a real-world analysis.

📖 Top 20% JournalArticle

2 days ago • Current problems in cardiology

Link between diabetes medicines and outcomes after pacemaker surgery in type 2 diabetes patientsAssociation of GLP-1 receptor agonist and SGLT2 inhibitor use with outcomes in patients with type 2 diabetes undergoing pacemaker implantation.

Article

2 days ago • Cureus

Heart Attack Without Major Artery Blockage After Large Weight Loss During Tirzepatide Treatment: A Case ReportNon-ST Elevation Myocardial Infarction Following Significant Weight Loss During Tirzepatide Therapy: A Case Report.

Case Reports

2 days ago • International journal of biological macromolecules

Design and testing of a long-lasting GLP-1 drug linked to albumin: structure, receptor activation, and functionDevelopment of an albumin-binding domain-fused GLP-1 analog: Structural insights, receptor activation, and functional characterization.

📖 Top 20% JournalArticle

2 days ago • Cureus

Skin Reactions Linked to Semaglutide: A Review and Combined Analysis of Clinical TrialsCutaneous Adverse Events With Semaglutide: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Article

3 days ago • Cureus

Lithium Poisoning After Starting Semaglutide in a Person With Bipolar DisorderLithium Toxicity Following Initiation of Semaglutide in a Patient With Bipolar Disorder: A Case Report.

Case Reports

3 days ago • Journal of translational medicine

Gut bacteria-produced butyrate may improve blood sugar control during pregnancy by activating hormone pathways through gene regulationThe gut microbiota-derived butyrate improves gestational glucose homeostasis through HDAC3 inhibition and epigenetic activation of the SCGN/GLP-1 axis.

🥉 Top 5% JournalArticle

3 days ago • Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

GLP-1 receptor agonist treatment linked to heart health in patients with fatty liver diseaseAssociation of GLP-1 receptor agonist therapy with cardiovascular outcomes in patients with MASLD: A translational study.

🎖️ Top 10% JournalArticle

3 days ago • Frontiers in endocrinology

Heart and kidney benefits of GLP-1 and dual GIP/GLP-1 receptor drugs beyond blood sugar controlBeyond glycemic control: cardiovascular and kidney benefits of GLP-1 receptor agonists and the dual GIP/GLP-1 receptor agonist tirzepatide: a narrative review.

🎖️ Top 10% JournalArticle

3 days ago • Cureus

Protecting Muscle Health During Weight Loss with Lifestyle, Surgery, and MedicationPreserving Muscle Health During Weight Loss: Evidence Across Lifestyle, Surgical, and Pharmacological Interventions.

Article

3 days ago • The AAPS journal

Using Charcoal to Reduce Drug Interference in Antibody Tests for Therapeutic PeptidesCharcoal-Based Depletion Method to Improve Drug Tolerance in Neutralizing Antibody Assays for Therapeutic Peptides.

🎖️ Top 10% JournalArticle

3 days ago • Frontiers in pharmacology

Pregnancy and birth outcomes after using GLP-1 and combined GLP-1/GIP receptor drugs during different timesPregnancy and perinatal outcomes following exposure to GLP-1 and dual GLP-1/GIP receptor agonists: a time-window-stratified systematic review and meta-analysis.

📖 Top 20% JournalArticle

3 days ago • Body image

How social influences relate to women's consideration of GLP-1 medication in the UKA test of the Tripartite Influence Model in the context of GLP-1 medication consideration among women in the United Kingdom.

🥉 Top 5% JournalArticle

3 days ago • Gynecologic oncology

Use of diabetes drugs that reduce appetite in obese patients with uterine cancer over timeTrends in use of glucagon-like peptide-1 receptor agonists in obese patients with endometrial cancer.

🎖️ Top 10% JournalArticle

3 days ago • Endocrine

Blood sugar control and weight loss with combined basal insulin and GLP-1 treatments in type 2 diabetesGlycemic control and weight loss benefits of fixed-ratio combinations of basal insulins and GLP1 receptor agonists in type 2 diabetes: A systematic review and network meta-analysis.

Systematic Review

3 days ago • Molecular metabolism

Targeting a specific stress-related receptor reduces fat, builds muscle, and improves blood sugar control in early obesityDifferentiated obesity treatment: Pharmacological CRF2 agonism drives fat loss, skeletal muscle hypertrophy and improved glucose metabolism in preclinical obesity.

🥉 Top 5% JournalArticle

← prevpage 1 of 16next →